15 January 2024
Malaysia
Sanofi’s MenQuadfi® (MAL 23076024ARZ) Approved In Malaysia For Prevention Of Meningococcal Disease
New quadrivalent meningococcal conjugate vaccine approved for use in persons aged 12 months and older. Safety and effectiveness have been evaluated in a series of double-blind, randomised clinical trials.